This is a preview of subscription content, log in via an institution to check access.
References
Ayd Jr., F. J.: Chemical treatment of depression. Ann. N.Y. Acad. Sci. 80, 734–744 (1959).
Bailey, A. S., L. Bucci, E. Gosline, N. S. Kline, I. H. Park, D. Rochlin, J. C. Saunders and M. Vasiburg: Comparison of iproniazid with other amine oxidase inhibitors including W 544, JB 516, RO 4-1018 and RO 5-0700. Ann. N.Y. Acad. Sci. 80, 652–668 (1959).
Bertler, A., A. Carlsson and E. Rosengren: A method for the fluorimetric determination of adrenaline and noradrenaline in tissue. Aeta physiol. scand. 44, 273–292 (1958).
Bradley, P. B., and A. J. Hance: The effect of chlorpromazine and methopromazine on the electrical activity of the brain in the cat. Electroenceph. clin. Neurophysiol. 9, 191–215 (1957).
Costa, E., and G. R. Pscheidt: Correlations between active eyelid closure and depletion of brain biogenic amines by reserpine. Proc. Soc. exp. Biol. (N.Y.) 106, 693–696 (1961).
— —, W. G. van Meter and H. E. Himwich: Brain concentrations of biogenic amines and EEG patterns of rabbits. J. Pharmacol. exp. Ther. 130, 81–88 (1960).
Garven, J.: The estimation of 5-hydroxytryptamine in the presence of adrenaline. Brit. J. Pharmacol. 11, 66–70 (1956).
Grieg, M. E.: Personal communication 1962.
— and W. A. Freyburger: The pharmacology of etryptamine. J. Neuropsychiat. 2, Suppl. I, 131–135 (1961).
—, R. A. Walk and A. J. Gibbons: The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo. J. Pharmacol. exp. Ther. 127, 110–115 (1959).
Meter, W. van, E. Costa, G. Ayala and H. E. Himwich: Behavioral, EEG and biochemical variations after the administration of α-methyltryptamine (IT 403). Recent advances in biological psychiatry, vol. 3, pp. 166–177. New York: Grune & Stratton 1961.
Rinaldi, F., and H. E. Himwich: Alerting responses and actions of atropine and cholinergic drugs. Arch. Neurol. Psychiat. (Chic.) 73, 387–395 (1955).
Sawyer, C. H., J. W. Everett and J. D. Green: The rabbit diencephalon in stereotaxic coordinates. J. comp. Neurol. 101, 801–824 (1954).
Steiner, W. G., and H. E. Himwich: Central cholinolytic action of chlorpromazine. Science 136, 873–875 (1962).
Vogt, Marthe: The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954).
White, R. P., and E. A. Daigneault: The antagonism of atropine to the EEG effects of adrenergic drugs. J. Pharmacol. exp. Ther. 125, 339–346 (1959).
Wikler, A.: Pharmacologic dissociation of behavior and EEG “sleep patterns” in dogs: Morphine, N-allymorphine and atropine. Proc. Soc. exp. Biol. (N.Y.) 79, 261–265 (1952).
Author information
Authors and Affiliations
Additional information
Etryptamine, registered under the trade name of Monase by the Upjohn Company, has been withdrawn as a clinical therapeutic due to its adverse effect on blood forming elements.
Rights and permissions
About this article
Cite this article
Steiner, W.G., Pscheidt, G.R., Costa, E. et al. α-Ethyltryptamine (etryptamine): An electroencephalographic, behavioral and neurochemical analysis. Psychopharmacologia 4, 354–366 (1963). https://doi.org/10.1007/BF00405246
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00405246